ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The innovative model based on artificial intelligence algorithms to predict recurrence risk of patients with postoperative breast cancer

Zeng, Lixuan; Liu, Lei; Chen, Dongxin; Lu, Henghui; Xue, Yang; Bi, Hongjie; Yang, Weiwei*哈尔滨医科大学
Frontiers in Oncology2023-3-7DOI: 10.3389/fonc.2023.1117420
1被引8阅读
引用收藏
分享

摘要

PurposeThis study aimed to develop a machine learning model to retrospectively study and predict the recurrence risk of breast cancer patients after surgery by extracting the clinicopathological features of tumors from unstructured clinical electronic health record (EHR) data. MethodsThis retrospective cohort included 1,841 breast cancer patients who underwent surgical treatment. To extract the principal features associated with recurrence risk, the clinical notes and histopathology reports of patients were collected and feature engineering was used. Predictive models were next conducted based on this important information. All algorithms were implemented using Python software. The accuracy of prediction models was further verified in the test cohort. The area under the curve (AUC), precision, recall, and F1 score were adopted to evaluate the performance of each model. ResultsA training cohort with 1,289 patients and a test cohort with 552 patients were recruited. From 2011 to 2019, a total of 1,841 textual reports were included. For the prediction of recurrence risk, both LSTM, XGBoost, and SVM had favorable accuracies of 0.89, 0.86, and 0.78. The AUC values of the micro-average ROC curve corresponding to LSTM, XGBoost, and SVM were 0.98 +/- 0.01, 0.97 +/- 0.03, and 0.92 +/- 0.06. Especially the LSTM model achieved superior execution than other models. The accuracy, F1 score, macro-avg F1 score (0.87), and weighted-avg F1 score (0.89) of the LSTM model produced higher values. All P values were statistically significant. Patients in the high-risk group predicted by our model performed more resistant to DNA damage and microtubule targeting drugs than those in the intermediate-risk group. The predicted low-risk patients were not statistically significant compared with intermediate- or high-risk patients due to the small sample size (188 low-risk patients were predicted via our model, and only two of them were administered chemotherapy alone after surgery). The prognosis of patients predicted by our model was consistent with the actual follow-up records. ConclusionsThe constructed model accurately predicted the recurrence risk of breast cancer patients from EHR data and certainly evaluated the chemoresistance and prognosis of patients. Therefore, our model can help clinicians to formulate the individualized management of breast cancer patients.

学科与关键词

关键词
breast cancerrecurrence riskLSTMXGBoostSVM
相关
加载中…
  • Machine Learning Algorithms to Predict Breast Cancer Recurrence Using Structured and Unstructured Sources from Electronic Health Records
    Gonzalez-Castro, Lorena; Chavez, Marcela; Duflot, Patrick; Bleret, Valerie; Martin, Alistair G.; Zobel, Marc; Nateqi, Jama; Lin, Simon; Pazos-Arias, Jose J.; Del Fiol, Guilherme; Lopez-Nores, MartinCancers, 2023, 15(10): 2741.被引 5
  • Machine learning-based models for the prediction of breast cancer recurrence risk
    Zuo, Duo; Yang, Lexin; Jin, Yu; Qi, Huan; Liu, Yahui; Ren, Li*BMC Medical Informatics and Decision Making, 2023, 23(1): 276.被引 9
  • Predicting the Recurrence of Ovarian Cancer Based on Machine Learning
    Zhou, Lining; Hong, Hong; Chu, Fuying; Chen, Xiang*; Wang, Chenlu*Cancer Management and Research, 2024, 16: 1375-1387.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2023-03-07
卷期
第 13 卷
页码
1117420
DOI
10.3389/fonc.2023.1117420
成果收录
SCIE
资助标注
Heilongjiang Province Postdoctoral Scientific Research Developmental Fund [LBH-Q20046]; Natural Science Foundation of Heilongjiang Province of China [LH2022H008]

作者

  • Z

    Zeng, Lixuan (第一作者)

    harbin med univ

  • L

    Liu, Lei

    harbin med univ

查看全部 7 位作者收起作者
  • C

    Chen, Dongxin

    harbin med univ

  • L

    Lu, Henghui

    2 · harbin med univ

  • X

    Xue, Yang

    harbin med univ

  • B

    Bi, Hongjie

    harbin med univ

  • Y

    Yang, Weiwei (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417